APUS Apimeds Pharmaceuticals US, Inc.
NEUTRAL
Impact: 2/10
8-K
8-K context-dependent: Items 5.02
Latest settled — T+20d
APUS ▼ -56.00% at T+20d
NEUTRAL call ✗ call lost -56.00% · α vs SPY -60.95% · entry $3.00 → $1.32
Last close $1.28 (close Jun 8) · -57.33% from $3.00 entry
T+1d
-35.00%
call -35.00% · α -36.38%
$1.95
settled 5w ago
T+5d
-55.33%
call -55.33% · α -57.32%
$1.34
settled 29d ago
T+20d
-56.00%
call -56.00% · α -60.95%
$1.32
settled 7d ago
T+60d
—
call — · α —
—
in 7w
Price Chart
Loading chart...
Executive Summary
Apimeds Pharmaceuticals US appointed Sungjoon Chae as Co-CEO effective May 4, 2026, following a stockholder nomination. Compensation terms are not yet determined. The appointment is routine and carries no immediate financial implications.
Actionable Insight
This filing is routine and does not warrant immediate action. Monitor for future disclosure of Chae's compensation package and any strategic shifts that may accompany the co-CEO structure.
Key Facts
- Sungjoon Chae appointed Co-CEO effective May 4, 2026
- Appointment made pursuant to a stockholder nomination
- Compensation terms not yet determined; will be disclosed when finalized
- No family relationships or related party transactions with the appointee
- No departure of existing officers reported
Financial Impact
No financial impact identified from this filing
Market Snapshot
Exchange
NYSE
Sector
Pharmaceutical Preparations
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001213900-26-052036 |
| Document: 0001213900-26-052036-index-headers.html | 0001213900-26-052036 |
| Document: 0001213900-26-052036-index.html | 0001213900-26-052036 |
| Document: 0001213900-26-052036.txt | 0001213900-26-052036 |
3 reports for APUS
Track record builds as more directional reports settle.
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 5, 2026
5w ago
|
8-K
| $3.00 $1.32 | ▼ −56.00% | ▼ −60.95% | $1.28 (−57.33%) |
|
May 4, 2026
5w ago
|
8-K
| $1.88 $1.52 | ▲ +19.15% | ▲ +24.79% | $1.28 (+31.91%) |
|
Apr 16, 2026
7w ago
|
8-K
| $1.88 $1.37 | ▲ +27.13% | ▲ +32.50% | $1.28 (+31.91%) |
Showing 3 of 3
US Market Status
Market Closed — Opens in 6h 58m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access